Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Koch

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
4-(4-Fluoro-phen-yl)-1-(4-nitro-phen-yl)-3-(pyridin-4-yl)-1H-pyrazol-5-amineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Expert Opinion on Therapeutic Patents|May 21, 2015
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014)Matthias Gehringer, Felix Muth, Pierre Koch, et al.
Angewandte Chemie (International Ed. in English)|October 11, 2017
The Cysteinome of Protein Kinases as a Target in Drug DevelopmentApirat Chaikuad, Pierre Koch, Stefan A Laufer, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Photocaging of Pyridinylimidazole-Based Covalent JNK3 Inhibitors Affords Spatiotemporal Control of the Binding Affinity in Live CellsBeate Sandra Hoffelner, Stanislav Andreev, Nicole Plank, et al.
Analytical Biochemistry|May 30, 2017
Fluorescence polarization-based competition binding assay for c-Jun N-terminal kinases 1 and 2Francesco Ansideri, Marcel Dammann, Frank M Boeckler, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-[2-(4-Fluoro-phen-yl)-1H-pyrrol-3-yl]pyridineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Acta Crystallographica. Section E, Structure Reports Online|September 13, 2012
4-(4-Fluoro-phen-yl)-3-(pyridin-4-yl)-1-(2,4,6-trichloro-phen-yl)-1H-pyrazol-5-amineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Journal of Medicinal Chemistry|January 19, 2010
Pyridinylquinoxalines and pyridinylpyridopyrazines as lead compounds for novel p38 alpha mitogen-activated protein kinase inhibitorsPierre Koch, Hartmut Jahns, Verena Schattel, et al.
Chembiochem : a European Journal of Chemical Biology|November 26, 2010
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoidsMárcia Goettert, Verena Schattel, Pierre Koch, et al.
ACS Omega|November 10, 2018
The Symmetric Tetravalent Sulfhydryl-Specific Linker NATBA Facilitates a Combinatorial "Tool Kit" Strategy for Phage Display-Based Selection of Functionalized Bicyclic PeptidesChristoph Ernst, Julia Sindlinger, Dirk Schwarzer, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
4-(4-Fluoro-phen-yl)-1-(4-nitro-phen-yl)-3-(pyridin-4-yl)-1H-pyrazol-5-amineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Expert Opinion on Therapeutic Patents|May 21, 2015
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014)Matthias Gehringer, Felix Muth, Pierre Koch, et al.
Angewandte Chemie (International Ed. in English)|October 11, 2017
The Cysteinome of Protein Kinases as a Target in Drug DevelopmentApirat Chaikuad, Pierre Koch, Stefan A Laufer, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Photocaging of Pyridinylimidazole-Based Covalent JNK3 Inhibitors Affords Spatiotemporal Control of the Binding Affinity in Live CellsBeate Sandra Hoffelner, Stanislav Andreev, Nicole Plank, et al.
Analytical Biochemistry|May 30, 2017
Fluorescence polarization-based competition binding assay for c-Jun N-terminal kinases 1 and 2Francesco Ansideri, Marcel Dammann, Frank M Boeckler, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-[2-(4-Fluoro-phen-yl)-1H-pyrrol-3-yl]pyridineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Acta Crystallographica. Section E, Structure Reports Online|September 13, 2012
4-(4-Fluoro-phen-yl)-3-(pyridin-4-yl)-1-(2,4,6-trichloro-phen-yl)-1H-pyrazol-5-amineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Journal of Medicinal Chemistry|January 19, 2010
Pyridinylquinoxalines and pyridinylpyridopyrazines as lead compounds for novel p38 alpha mitogen-activated protein kinase inhibitorsPierre Koch, Hartmut Jahns, Verena Schattel, et al.
Chembiochem : a European Journal of Chemical Biology|November 26, 2010
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoidsMárcia Goettert, Verena Schattel, Pierre Koch, et al.
ACS Omega|November 10, 2018
The Symmetric Tetravalent Sulfhydryl-Specific Linker NATBA Facilitates a Combinatorial "Tool Kit" Strategy for Phage Display-Based Selection of Functionalized Bicyclic PeptidesChristoph Ernst, Julia Sindlinger, Dirk Schwarzer, et al.
Pageof 8